Incidence and Risk Factors of Late Target Lesion Revascularization After Sirolimus-Eluting Stent Implantation (3-Year Follow-Up of the j-Cypher Registry)
- 1 August 2010
- journal article
- research article
- Published by Elsevier BV in The American Journal of Cardiology
- Vol. 106 (3), 329-336
- https://doi.org/10.1016/j.amjcard.2010.03.031
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Two-Year Clinical, Angiographic, and Intravascular Ultrasound Follow-Up of the XIENCE V Everolimus-Eluting Stent in the Treatment of Patients With De Novo Native Coronary Artery LesionsCirculation: Cardiovascular Interventions, 2009
- Antiplatelet Therapy and Stent Thrombosis After Sirolimus-Eluting Stent ImplantationCirculation, 2009
- Late target lesion revascularization after implantation of sirolimus‐eluting stentCatheterization and Cardiovascular Interventions, 2007
- Late loss of early benefit from drug-eluting stents when compared with bare-metal stents and coronary artery bypass surgery: 3 years follow-up of the ERACI III registryEuropean Heart Journal, 2007
- Late Restenosis Following Sirolimus-Eluting Stent ImplantationThe American Journal of Cardiology, 2007
- Estimation of glomerular filtration rate by the MDRD study equation modified for Japanese patients with chronic kidney diseaseClinical and Experimental Nephrology, 2007
- Late Restenosis in Patients Receiving a Polymer-Coated Sirolimus-Eluting StentAnnals of Internal Medicine, 2005
- A Polymer-Based, Paclitaxel-Eluting Stent in Patients with Coronary Artery DiseaseThe New England Journal of Medicine, 2004
- Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary ArteryThe New England Journal of Medicine, 2003
- Angiographic Patterns of In-Stent RestenosisCirculation, 1999